Dr Suzanne Orchard and local ASPREE Senior Study Co-ordinator Rosalind (Ros) Whittaker hosted the first ASPREE study update for 2016 in Wollongong on March 17. “It was terrific to meet so many participants and guests at the ASPREE study update in Wollongong last week,” said senior research manager, Dr Suzanne Orchard, who is based at the ASPREE Head Office…Details
The ASPREE-Hearing research team continue their travels around south-eastern Australia in the name of science. They are tasked with collecting information which will be used to determine whether daily low-aspirin reduces or prevents age-related hearing loss. Ever since the mobile audiometers were calibrated late last year, the team hasn’t been still! This picture was taken in Shepparton earlier this month when the…Details
First hearing research paper describes rationale and design of low-dose aspirin and hearing progression Loss of hearing can have a profound effect on a person’s independence and quality of life. Up to two-thirds of people over the age of 70 years will experience hearing loss associated with ageing and there is no known single cause and no known cure.…Details
The President of Golden Days FM, Melbourne’s Senior Broadcast radio, recently spoke to Professor Andrew Tonkin, a senior investigator to the ASPREE trial on the progress of the study. Prof. Tonkin, Head of the Cardiovascular Research Unit at Monash University, oversees cardiovascular aspects of ASPREE. Our thanks to Larry James for the opportunity to discuss the study with listeners…Details
Popular ASPREE staff and nurses Sally and Gillian, were delighted to catch up with participants at study updates in Wangaratta on 25th February and Lavington (Albury) on 26th February this year. Associate Professor Robyn Woods, EO of ASPREE gave both presentations, accompanied by Dr Carlene Britt, who is the ASPREE Regional Manager. Pictured left is…Details
More than 700 ASPREE participants and guests attended ASPREE study updates at the Monash Biomedical Imaging (MBI) Centre on the 12th & 13th of February 2015. The larger crowd attended on Friday, suggesting that our audience is not at all superstitious. The ASPREE team thoroughly enjoyed the opportunity to meet our participants and to answer questions about the study.
Thanks to the wonderful support from older members of the community, their families and GPs, ASPREE hit a number of new milestones as it strove towards the recruitment target this year. Highlights of the year include: • ASPREE reached the recruitment target of 19,000 participants across both countries in November 2014; 16,700 participants are Australian.…Details
Chief Investigator to the ASPREE Study, Professor Mark Nelson hosted the Hobart study update at the Menzies Institute for Medical Research today. We’d like to thank our participants and their guests and Jess Stewart, daughter of ASPREE’s Hobart team member, Kirby Donaldson for the pics from today’s event.
PRESS RELEASE: Melbourne, December 1, 2014 – Australia’s largest clinical trial is a step closer to revealing in 2018 whether healthy older people should or should not take aspirin to prevent or delay cardiovascular disease (heart attack and stroke), dementia, depression and some types of cancers. ASPREE (ASPirin in Reducing Events in the Elderly), a…Details
Ballarat may have forgotten it was spring, but it didn’t put a dampener on meeting local ASPREE participants and guests at the study update today. We all braved the inclement weather – sun, sun, rain, downpour, FREEZING! (all in the space of a few hours) and look forward to the stories about the event on local Win News…Details